Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-02-17 Purchase |
2021-02-19 7:09 pm |
Decibel Therapeutics Inc. | DBTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VIII LLC OrbiMed Genesis GP LLC ORBIMED CAPITAL LLC Director 10% Owner |
1,666,666 | $18 | $29,999,988 | 883,418 (Indirect) |
View |
| 2021-02-17 Purchase |
2021-02-19 6:59 pm |
Decibel Therapeutics Inc. | DBTX | Foy Matthew Director 10% Owner |
150,000 | $18 | $2,700,000 | 1,183,663 (Indirect) |
View |
| 2021-02-17 Purchase |
2021-02-19 6:56 pm |
Decibel Therapeutics Inc. | DBTX | Casdin Partners Master Fund L.P. 10% Owner |
575,000 | $18 | $10,350,000 | 1,121,421 (Indirect) |
View |
| 2021-02-17 Purchase |
2021-02-19 6:50 pm |
Decibel Therapeutics Inc. | DBTX | Thompson Peter A. Director 10% Owner |
1,666,666 | $18 | $29,999,988 | 883,418 (Indirect) |
View |
| 2021-02-17 Purchase |
2021-02-19 4:50 pm |
Decibel Therapeutics Inc. | DBTX | GLAXOSMITHKLINE PLC Director |
150,000 | $18 | $2,700,000 | 1,183,663 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-06-02 Option Award |
2021-06-03 4:45 pm |
N/A 2031-06-01 |
Decibel Therapeutics Inc. | DBTX | Carson William H. Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2021-02-17 Conversion |
2021-03-08 5:35 pm |
N/A N/A |
Decibel Therapeutics Inc. | DBTX | Schroder Adveq Technology IX S.C.S. Schroder Adveq Management Luxembourg Sarl Schroder Adveq cPl Global 2017 - 2019 C.V. Schroder Adveq cPl Global Management III L.P. 10% Owner |
13,774,330 | $0 | 524,328 (Indirect) |
View |
Ownership |
2021-03-08 5:34 pm |
N/A N/A |
Decibel Therapeutics Inc. | DBTX | Schroder Adveq Technology IX S.C.S. Schroder Adveq Management Luxembourg Sarl Schroder Adveq cPl Global 2017 - 2019 C.V. Schroder Adveq cPl Global Management III L.P. 10% Owner |
0 | $0 | 1,048,656 (Indirect) |
View |
| 2021-02-17 Conversion |
2021-02-19 7:09 pm |
N/A N/A |
Decibel Therapeutics Inc. | DBTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VIII LLC OrbiMed Genesis GP LLC ORBIMED CAPITAL LLC Director 10% Owner |
20,654,719 | $0 | 883,418 (Indirect) |
View |
| 2021-02-17 Conversion |
2021-02-19 6:59 pm |
N/A N/A |
Decibel Therapeutics Inc. | DBTX | Foy Matthew Director 10% Owner |
13,016,134 | $0 | 1,183,663 (Indirect) |
View |
| 2021-02-17 Conversion |
2021-02-19 6:56 pm |
N/A N/A |
Decibel Therapeutics Inc. | DBTX | Casdin Partners Master Fund L.P. 10% Owner |
3,442,453 | $0 | 1,121,421 (Indirect) |
View |
| 2021-02-17 Conversion |
2021-02-19 6:50 pm |
N/A N/A |
Decibel Therapeutics Inc. | DBTX | Thompson Peter A. Director 10% Owner |
20,654,719 | $0 | 883,418 (Indirect) |
View |
| 2021-02-17 Conversion |
2021-02-19 6:50 pm |
N/A N/A |
Decibel Therapeutics Inc. | DBTX | Exter Neil Director 10% Owner |
50,271,001 | $0 | 3,139,685 (Indirect) |
View |
Ownership(A) |
2021-02-19 6:40 pm |
N/A N/A |
Decibel Therapeutics Inc. | DBTX | Exter Neil Director 10% Owner |
0 | $0 | 47,169 (Indirect) |
View |
| 2021-02-17 Conversion |
2021-02-19 4:50 pm |
N/A N/A |
Decibel Therapeutics Inc. | DBTX | GLAXOSMITHKLINE PLC Director |
13,016,132 | $0 | 1,183,663 (Indirect) |
View |
| 2021-02-17 Conversion |
2021-02-18 5:40 pm |
N/A N/A |
Decibel Therapeutics Inc. | DBTX | Longevity Fund 2 LP 10% Owner |
79,143 | $0 | 79,143 (Direct) |
View |
| 2021-02-17 Conversion |
2021-02-18 4:01 pm |
N/A N/A |
Decibel Therapeutics Inc. | DBTX | REGENERON PHARMACEUTICALS INC. 10% Owner |
28,597,314 | $0 | 2,097,314 (Direct) |
View |
| 2021-02-17 Conversion |
2021-02-17 7:45 pm |
N/A N/A |
Decibel Therapeutics Inc. | DBTX | GV 2019 GP L.L.C. GV 2019 GP L.P. GV 2019 L.P. 10% Owner |
5,163,679 | $0 | 819,631 (Indirect) |
View |
| 2021-02-17 Conversion |
2021-02-17 7:42 pm |
N/A N/A |
Decibel Therapeutics Inc. | DBTX | GV 2017 GP L.L.C. GV 2017 GP L.P. GV 2017 L.P. 10% Owner |
6,744,649 | $0 | 494,649 (Indirect) |
View |
| 2021-02-17 Conversion |
2021-02-17 7:38 pm |
N/A N/A |
Decibel Therapeutics Inc. | DBTX | GV 2016 GP L.L.C. GV 2016 GP L.P. GV 2016 L.P. 10% Owner |
5,321,978 | $0 | 321,978 (Indirect) |
View |
| 2021-02-11 Option Award |
2021-02-16 5:41 pm |
N/A 2031-02-10 |
Decibel Therapeutics Inc. | DBTX | Foy Matthew Director 10% Owner |
20,000 | $0 | 20,000 (Direct) |
View |
| 2021-02-11 Option Award |
2021-02-16 5:37 pm |
N/A 2031-02-10 |
Decibel Therapeutics Inc. | DBTX | POON CHRISTINE A Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2021-02-11 Option Award |
2021-02-16 5:34 pm |
N/A 2031-02-10 |
Decibel Therapeutics Inc. | DBTX | Exter Neil Director 10% Owner |
20,000 | $0 | 20,000 (Direct) |
View |
| 2021-02-11 Option Award |
2021-02-16 4:50 pm |
N/A 2031-02-10 |
Decibel Therapeutics Inc. | DBTX | Thompson Peter A. Director 10% Owner |
20,000 | $0 | 20,000 (Direct) |
View |
Ownership |
2021-02-12 08:32 am |
N/A N/A |
Decibel Therapeutics Inc. | DBTX | Third Rock Ventures III L.P. Third Rock Ventures GP III L.P. TRV GP III LLC LEVIN MARK J STARR KEVIN P TEPPER ROBERT I 10% Owner |
0 | $0 | 3,139,685 (Direct) |
View |
Ownership |
2021-02-11 9:29 pm |
N/A N/A |
Decibel Therapeutics Inc. | DBTX | Casdin Partners Master Fund L.P. 10% Owner |
0 | $0 | 546,421 (Indirect) |
View |
Ownership |
2021-02-11 9:20 pm |
N/A N/A |
Decibel Therapeutics Inc. | DBTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VIII LLC OrbiMed Genesis GP LLC ORBIMED CAPITAL LLC 10% Owner |
0 | $0 | 3,278,526 (Indirect) |
View |
Ownership |
2021-02-11 9:17 pm |
N/A N/A |
Decibel Therapeutics Inc. | DBTX | Foy Matthew Director 10% Owner |
0 | $0 | 1,033,663 (Indirect) |
View |
Ownership |
2021-02-11 9:16 pm |
N/A N/A |
Decibel Therapeutics Inc. | DBTX | Steven H. Holtzman Revocable Trust 10% Owner |
0 | $0 | 67,786 (Direct) |
View |
Ownership |
2021-02-11 9:14 pm |
N/A N/A |
Decibel Therapeutics Inc. | DBTX | Lee John Jui-Jen See Remarks |
0 | $0 | 259,147 (Direct) |
View |
Ownership |
2021-02-11 9:13 pm |
N/A N/A |
Decibel Therapeutics Inc. | DBTX | Exter Neil Director 10% Owner |
0 | $0 | 3,092,516 (Indirect) |
View |
Ownership |
2021-02-11 9:10 pm |
N/A N/A |
Decibel Therapeutics Inc. | DBTX | Thompson Peter A. Director 10% Owner |
0 | $0 | 3,278,526 (Indirect) |
View |
Ownership |
2021-02-11 9:08 pm |
N/A N/A |
Decibel Therapeutics Inc. | DBTX | Reid Laurence See Remarks |
0 | $0 | 1,088,388 (Direct) |
View |
Ownership |
2021-02-11 9:07 pm |
N/A 2030-12-07 |
Decibel Therapeutics Inc. | DBTX | Leiderman Elisabeth See Remarks |
0 | $0 | 207,312 (Direct) |
View |
Ownership |
2021-02-11 9:07 pm |
N/A N/A |
Decibel Therapeutics Inc. | DBTX | Trask Anna See Remarks |
0 | $0 | 155,490 (Direct) |
View |
Ownership |
2021-02-11 9:04 pm |
N/A N/A |
Decibel Therapeutics Inc. | DBTX | Vigliotta Ronald See Remarks |
0 | $0 | 120,608 (Direct) |
View |
Ownership |
2021-02-11 9:04 pm |
N/A N/A |
Decibel Therapeutics Inc. | DBTX | GLAXOSMITHKLINE PLC Director 10% Owner |
0 | $0 | 1,033,663 (Indirect) |
View |
Ownership |
2021-02-11 9:03 pm |
N/A 2029-06-18 |
Decibel Therapeutics Inc. | DBTX | POON CHRISTINE A Director |
0 | $0 | 4,716 (Direct) |
View |
Ownership |
2021-02-11 7:31 pm |
N/A N/A |
Decibel Therapeutics Inc. | DBTX | Longevity Fund 2 LP 10% Owner |
0 | $0 | 79,143 (Direct) |
View |
Ownership |
2021-02-11 5:27 pm |
N/A N/A |
Decibel Therapeutics Inc. | DBTX | GV 2019 GP L.L.C. GV 2019 GP L.P. GV 2019 L.P. 10% Owner |
0 | $0 | 819,631 (Indirect) |
View |
Ownership |
2021-02-11 5:25 pm |
N/A N/A |
Decibel Therapeutics Inc. | DBTX | GV 2017 GP L.L.C. GV 2017 GP L.P. GV 2017 L.P. 10% Owner |
0 | $0 | 494,649 (Indirect) |
View |
Ownership |
2021-02-11 5:23 pm |
N/A N/A |
Decibel Therapeutics Inc. | DBTX | GV 2016 GP L.L.C. GV 2016 GP L.P. GV 2016 L.P. 10% Owner |
0 | $0 | 321,978 (Indirect) |
View |
Ownership |
2021-02-11 5:01 pm |
N/A N/A |
Decibel Therapeutics Inc. | DBTX | REGENERON PHARMACEUTICALS INC. 10% Owner |
0 | $0 | 2,097,314 (Direct) |
View |